Bellco Capital
Overview
Bellco Capital is a direct investment firm that focuses on deploying capital to create and support companies with bold ambitions of exponential transformation in life sciences as well as growth in real estate, consumer products, media and other sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ginkgo Bioworks | Sep 2021 | IPO | Co-investor |
| Neumora | Oct 2022 | Series B | - |
| ByHeart | May 2024 | Series C | Co-investor |
| Cargo Therapeutics | Mar 2023 | Series A | - |
| Dewpoint Therapeutics | Sep 2020 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bellco Capital based?
Bellco Capital is headquartered in Los Angeles, California, United States.
When was Bellco Capital founded?
Bellco Capital was founded in 2003.
How many portfolio companies does Bellco Capital have?
Bellco Capital has 11 portfolio companies in Caplight's dataset.
What are some companies in Bellco Capital's portfolio?
Portfolio companies visible on Caplight include Ginkgo Bioworks, Neumora, ByHeart, Cargo Therapeutics, Dewpoint Therapeutics.
What was Bellco Capital's most recent investment shown here?
Bellco Capital's most recent investment in this portfolio sample was in ByHeart in 2024.
What sectors does Bellco Capital focus on?
Bellco Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences.
What company stages does Bellco Capital focus on?
Bellco Capital typically invests at the Early stage.
What is Bellco Capital's AUM?
Bellco Capital's assets under management are estimated between $500.0M and $1.0B.